Wang Yuli, Dai Jingjing, Chang Xinyi, Yang Meiyan, Shen Ruifang, Shan Li, Qian Yong, Gao Chunsheng
Department of Pharmaceutics, Beijing Institute of Pharmacology and Toxicology, No. 27, Taiping Road, Haidian District, Beijing, 100850, People's Republic of China.
AAPS PharmSciTech. 2015 Feb;16(1):35-44. doi: 10.1208/s12249-014-0197-5. Epub 2014 Aug 28.
The objective of the present study was to evaluate the feasibility of using model drug metoprolol succinate (MS) as a pore former to modify the initial lag phase (i.e., a slow or non-release phase in the first 1-2 h) associated with the drug release from coated pellets. MS-layered cores with high drug-layering efficiency (97% w/w) were first prepared by spraying a highly concentrated drug aqueous solution (60% w/w, 70°C) on non-pareils without using other binders. The presence of MS in ethylcellulose (EC) coating solution significantly improved the coating process by reducing pellets sticking, which often occurs during organic coating. There may be a maximum physical compatibility of MS with EC, and the physical state of the drug in the functional coating layer of EC/MS (80:20) was simultaneously crystalline and non-crystalline (amorphous or solid molecule solution). The lag phase associated with hydroxypropylcellulose (HPC) as a pore former was not observed when MS was used as a pore former. The drug release from EC/MS-coated pellets was pH independent, inversely proportional to the coating levels, and directly related to the pore former levels. The functional coating layer with MS as a pore former was not completely stabilized without curing. Curing at 60°C for 1 day could substantially improve the stability of EC/MS-coated pellets. The physical state of the drug in the free film of EC/MS (85:15) changed partially from amorphous to crystal when cured at 60°C for 1 day, which should be attributed to the incompatibility of the drug with EC.
本研究的目的是评估使用模型药物琥珀酸美托洛尔(MS)作为成孔剂来改善与包衣微丸药物释放相关的初始延迟期(即最初1-2小时的缓慢或无释放阶段)的可行性。首先通过在不使用其他粘合剂的情况下,将高浓度药物水溶液(60%w/w,70°C)喷洒在空白丸芯上,制备出具有高药物层铺效率(97%w/w)的MS层芯。乙基纤维素(EC)包衣溶液中MS的存在通过减少包衣过程中经常出现的微丸粘连现象,显著改善了包衣工艺。MS与EC之间可能存在最大物理相容性,并且在EC/MS(80:20)功能包衣层中药物的物理状态同时为结晶态和非结晶态(无定形或固体分子溶液)。当使用MS作为成孔剂时,未观察到与作为成孔剂的羟丙基纤维素(HPC)相关的延迟期。从EC/MS包衣微丸释放的药物与pH无关,与包衣水平成反比,与成孔剂水平直接相关。以MS作为成孔剂的功能包衣层未经固化则不完全稳定。在60°C下固化1天可显著提高EC/MS包衣微丸的稳定性。当在60°C下固化1天时,EC/MS(85:15)自由膜中药物的物理状态部分从无定形变为结晶态,这应归因于药物与EC的不相容性。